FIL1L anticorps (Middle Region)
Aperçu rapide pour FIL1L anticorps (Middle Region) (ABIN631303)
Antigène
Voir toutes FIL1L (FILIP1L) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- FILIP1 L antibody was raised against the middle region of FILIP1
-
Purification
- Affinity purified
-
Immunogène
- FILIP1 L antibody was raised using the middle region of FILIP1 corresponding to a region with amino acids KSLRPSLNGRRISDPQVFSKEVQTEAVDNEPPDYKSLIPLERAVINGQLY
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
FILIP1L Blocking Peptide, (ABIN940041), is also available for use as a blocking control in assays to test for specificity of this FILIP1L antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of FILIP0 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- FIL1L (FILIP1L) (Filamin A Interacting Protein 1-Like (FILIP1L))
-
Autre désignation
- FILIP1L
-
Sujet
- FILIP1L acts as a regulator of the antiangiogenic activity on endothelial cells. When overexpressed in endothelial cells, FILIP1L leads to inhibition of cell proliferation and migration and an increase in apoptosis.
-
Poids moléculaire
- 102 kDa (MW of target protein)
Antigène
-